PENTAX Medical America has introduced the new PlasmaTYPHOONdry endoscope drying solution.
The new fast endoscope drying solution is a patented, completely automated process which uses an advanced technique to drying with two different airflow levels.
It can be used on the next patient or placed into storage after completing the drying process.
The PlasmaTYPHOONdry has been designed for improving productivity and traceability.
It can be added to the reprocessing regimen with fast cycle times of one to five minutes. This can be done with less interruption in daily routines.
The device reduces delays in reprocessing and supports the requirements of nurses, physicians, and reprocessing staff working a multitude of departments.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe company stated that the new PlasmaTYPHOONdry further advances the endoscope drying to improve patient safety.
PENTAX Americas president Ojas Buch said: “Recent changes to industry standards have further highlighted the need to dry endoscope channels after reprocessing, prior to use, and prior to storage. PlasmaTYPHOONdry reinforces PENTAX Medical’s commitment to the GI community and addressing its unmet needs.”
The company aims to develop innovative products, optimise the processes, and integrate feedback from the market to tackle infection prevention needs of customers and patient safety.
In June last year, PENTAX Medical formed a joint venture (JV) with Jiangsu Vedkang Medical Science and Technology to develop single-use, flexible medical endoscopic therapeutic products.
Named PENTAX Medical Therapeutics (Jiangsu), the JV was formed to use the marketing network of the company to offer advanced single-use devices to clients across the world.